Zelira Therapeutics (AU:ZLD)
ASX:ZLD
Holding AU:ZLD?
Track your performance easily

Zelira Therapeutics (ZLD) Financial Statements

2 Followers

Zelira Therapeutics Financial Overview

Zelira Therapeutics's market cap is currently ―. The company's EPS TTM is AU$-3.219; its P/E ratio is -0.23; Zelira Therapeutics is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 2.75MAU$ 4.97MAU$ 1.70MAU$ 3.07MAU$ 5.69M
Total AssetsAU$ 37.70MAU$ 39.37MAU$ 35.79MAU$ 3.52MAU$ 6.31M
Total DebtAU$ 500.91KAU$ 551.08KAU$ 632.32KAU$ 0.00AU$ 0.00
Net DebtAU$ -2.25MAU$ -4.42MAU$ -1.06MAU$ -3.07MAU$ -5.69M
Total LiabilitiesAU$ 2.01MAU$ 1.54MAU$ 1.24MAU$ 407.24KAU$ 99.42K
Stockholders EquityAU$ 35.20MAU$ 37.83MAU$ 34.55MAU$ 3.11MAU$ 6.21M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

Zelira Therapeutics Debt to Assets

Zelira Therapeutics Cash Flow

Zelira Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis